Business
Switzerland leads Europe in university spinout value per capita and STEM graduates.
Hi, what are you looking for?
Switzerland leads Europe in university spinout value per capita and STEM graduates.
XPro is being developed primarily for Alzheimer’s disease and mild cognitive impairment. It is a next-generation anti-TNF biologic.
Future Fields CEO Matt Anderson-Baron shares the raw lessons and hard pivots behind building a biotech company during Life Sciences Week in Edmonton.
Alberta’s $4.8-billion life sciences sector is scaling, but growth depends on closing gaps in regulation, talent, and capital across Canada.
Canada’s biotech future hinges on risk. Nobel Laureate Sir Michael Houghton urges a VC mindset shift to stop exporting innovation before it scales.
BioAlberta’s CEO reflects on regulatory hurdles, investor gaps, and the leadership needed to turn scientific breakthroughs into commercial success.
Nucleate Canada’s upcoming Forum offers the first national look at a grassroots model for biotech commercialization.
The sector has grown from its early days of molecule discoveries into an ecosystem that includes biotech, medical devices, digital health, and AI.
It may look like an innocent green plant, but its name evokes something far closer to a robot or interstellar rocket. Neo Px is...
At the core of the discussion, panel participants will cover topics such as gene editing and other tools that are ushering in a new...